Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias

Completed · Phase 2

Conditions studied: Porphyria

In brief

OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute intermittent porphyria. II. Evaluate and compare the safety and tolerability of these treatment regimens in this patient population.

Key facts

Study ID

NCT00004396

Run by

National Center for Research Resources (NCRR)

People needed

32

Starts

1997-09-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Rockefeller University Hospital — New York, New York, United States
• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.